Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -109,089 | -44,187 | -168,099 | -129,272 | -87,887 |
| Depreciation Amortization | 300 | 231 | 2,959 | 2,530 | 1,896 |
| Accounts payable and accrued liabilities | -7,897 | -6,531 | -1,235 | -5,881 | -4,724 |
| Other Working Capital | -3,722 | -7,921 | -5,379 | -10,535 | -5,380 |
| Other Operating Activity | 17,858 | 11,500 | 18,109 | 18,705 | 14,447 |
| Operating Cash Flow | $-102,550 | $-46,908 | $-153,645 | $-124,453 | $-81,648 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -34,684 | -16,687 | -121,176 | -94,712 | -89,530 |
| PPE Investments | -480 | -230 | -3,067 | -2,548 | -1,662 |
| Purchase Of Investment | 77,629 | 42,150 | 208,291 | 162,466 | 104,740 |
| Sale Of Investment | 1,829 | 1,829 | 3,154 | 2,759 | 2,759 |
| Investing Cash Flow | $44,294 | $27,062 | $87,202 | $67,965 | $16,307 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 53,721 | 28,815 | 37,390 | 187 | 117 |
| Financing Cash Flow | $53,721 | $28,815 | $37,390 | $187 | $117 |
| Beginning Cash Position | 174,466 | 174,466 | 203,519 | 203,519 | 203,519 |
| End Cash Position | 169,931 | 183,435 | 174,466 | 147,218 | 138,295 |
| Net Cash Flow | $-4,535 | $8,969 | $-29,053 | $-56,301 | $-65,224 |
| Free Cash Flow | |||||
| Operating Cash Flow | -102,550 | -46,908 | -153,645 | -124,453 | -81,648 |
| Capital Expenditure | -480 | -230 | -3,067 | -2,548 | -1,662 |
| Free Cash Flow | -103,030 | -47,138 | -156,712 | -127,001 | -83,310 |